A Phase 3 interventional study of Dexmedetomidine Hydrochloride Nasal Spray and Dexmedetomidine hydrochloride nasal spray blank preparation in Preoperative Sedation of Children, sponsored by Shanghai Hengrui Pharmaceutical Co., Ltd.. Completed at 1 site in China. Open to participants aged 2 Years to 6 Years. Per ClinicalTrials.gov, last updated 2022-11-07.
Sponsored by Shanghai Hengrui Pharmaceutical Co., Ltd. (part of Jiangsu HengRui Medicine Co., Ltd.) · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The study is being conducted to evaluate the efficacy, and safety of dexmedetomidine hydrochloride nasal spray for preoperative sedation in children.
Shanghai Hengrui Pharmaceutical Co., Ltd. is the lead sponsor of 61 studies on the registry; 30 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hemoglobin (Hb)
The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: Dexmedetomidine Hydrochloride Nasal Spray
Drug: Dexmedetomidine hydrochloride nasal spray blank preparation
In the low weight group, the subjects will receive a low dose of dexmedetomidine nasal spray. In the high weight group, the subjects will receive a high dose of dexmedetomidine nasal spray.
In the low weight group, the subjects will receive dexmedetomidine hydrochloride nasal spray blank preparation. In the high weight group, the subjects will receive dexmedetomidine hydrochloride nasal spray blank preparation.
Proportion of subjects who meet parent-child separation successful
Time frame: within 45 minutes after the beginning of administration
Proportion of subjects who meet the Ramsay sedation score of 3 at least once within 45 minutes after the beginning of administration
Time frame: within 45 minutes after the beginning of administration
Proportion of subjects who meet parent-child separation successful within 45 minutes after the beginning of administration
The FUNK scale is a scale of 1 to 4 for sedation, anxiety, and separation from parents. Separation success is defined as a scale of 3 or 4 per item.
Time frame: Within 45 minutes after the beginning of administration
Time from the beginning of administration to the successful parent-child separation for the first time through study completion,an average of 3 days
The FUNK scale is a scale of 1 to 4 for sedation, anxiety, and separation from parents. Separation success is defined as a scale of 3 or 4 per item.
Time frame: an average of 3 days
Proportion of subjects whose the Ramsay score is satisfactory at least once within 45 minutes after the beginning of administration
Sedation level using the Ramsay scale. Ramsay Satisfaction is defined as a scale of ≥ 3.
Time frame: Within 45 minutes after the beginning of administration
Time from the beginning of administration to the satisfactory Ramsay score for the first time
Sedation level using the Ramsay scale. Ramsay Satisfaction is defined as a scale of ≥ 3.
Time frame: from the beginning of administration to the first successful Ramsay score
Proportion of subjects whose the UMSS Scale is satisfactory at least once within 45 minutes after the beginning of administration
Sedation level using the University of Michigan Sedation Scale. UMSS satisfaction is defined as a scale of ≥ 2 .
Time frame: within 45 minutes after the beginning of administration
Time from the beginning of administration to the satisfactory UMSS score for the first time through study completion,an average of 3 days
Sedation level using the University of Michigan Sedation Scale. UMSS satisfaction is defined as a scale of ≥ 2.
Time frame: an average of 3 days
Time of anesthesia awakening through study completion,an average of 3 days
Time frame: an average of 3 days
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Nov 2021 to primary completion in May 2022, 5 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Dexmedetomidine
Shanghai Hengrui Pharmaceutical Co., Ltd. →